Aims The prevention and early recognition of eating disorders (EDs) are important topics in publichealth. This study aims to compare the efficacy of the Eating Disorder Inventory 2 (EDI-2) with thenew version, EDI-3 in recognising patients and identifying subjects at risk for EDs.Methods The EDI-2 and EDI-3 were administered to 92 female patients with ED and 265 femalesfrom a population at risk for EDs. Experienced psychiatrists in this field held blind interviews withparticipants by means of the SCID-I to determine the diagnosis.Results According to the cut-offs suggested by the authors, the EDI-3 correctly identified nearly allof the ED patients (99%), while the EDI-2 divulged less than half (48%). Both versions of the testshowed comparable capability to identify participants at risk for EDs but the EDI-3 seemed slightlymore reliable than the EDI-2.Conclusions The EDI-2 remains a valid and very specific test. However, the new EDI-3 seems to beexperimentally superior, because it typifies nearly all patients across the ED span, including thosewith Binge Eating Disorder and Eating Disorder Not Otherwise Specified. In addition, it appears tobe more reliable.

Ability of EDI-2 and EDI-3 to correctly identify patients and subjects at risk for eating disorders

Segura Garcia C
Conceptualization
;
Aloi M;Rania M;Ciambrone P;Palmieri A;Pugliese V;De Fazio P
2015-01-01

Abstract

Aims The prevention and early recognition of eating disorders (EDs) are important topics in publichealth. This study aims to compare the efficacy of the Eating Disorder Inventory 2 (EDI-2) with thenew version, EDI-3 in recognising patients and identifying subjects at risk for EDs.Methods The EDI-2 and EDI-3 were administered to 92 female patients with ED and 265 femalesfrom a population at risk for EDs. Experienced psychiatrists in this field held blind interviews withparticipants by means of the SCID-I to determine the diagnosis.Results According to the cut-offs suggested by the authors, the EDI-3 correctly identified nearly allof the ED patients (99%), while the EDI-2 divulged less than half (48%). Both versions of the testshowed comparable capability to identify participants at risk for EDs but the EDI-3 seemed slightlymore reliable than the EDI-2.Conclusions The EDI-2 remains a valid and very specific test. However, the new EDI-3 seems to beexperimentally superior, because it typifies nearly all patients across the ED span, including thosewith Binge Eating Disorder and Eating Disorder Not Otherwise Specified. In addition, it appears tobe more reliable.
2015
EDI-2; EDI-3; eating disorders; clinical typification; screening
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12317/6124
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 22
social impact